MORGAN STANLEY PLC/CALL/PFIZER INC/60/0.1/20.12.24 Share Price

Warrant

DE000MB335B2

Market Closed - Bid/Ask 12:42:01 28/05/2024 pm IST After market 11:30:07 pm
0.006 EUR 0.00% Intraday chart for MORGAN STANLEY PLC/CALL/PFIZER INC/60/0.1/20.12.24 0.024 +300.00%
Current month-40.00%
1 month-40.00%
Date Price Change
28/24/28 0.006 0.00%
27/24/27 0.006 -14.29%
24/24/24 0.007 0.00%
23/24/23 0.007 0.00%
22/24/22 0.007 0.00%

Delayed Quote Börse Stuttgart

Last update May 28, 2024 at 12:42 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying PFIZER, INC.
Issuer Morgan Stanley
WKN MB335B
ISINDE000MB335B2
Date issued 01/02/2023
Strike 60 $
Maturity 20/12/2024 (206 Days)
Parity 10 : 1
Emission price 0.2
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.18
Lowest since issue 0.005
Spread 0.033
Spread %82.50%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.88 USD
Average target price
31.92 USD
Spread / Average Target
+10.51%
Consensus